Fort Capital Partners is pleased to announce that Nexii Building Solutions Inc. (“Nexii” or the “Company”) has completed the acquisition of Omicron Canada Ltd. (“Omicron”).
Nexii is a leading green construction technology company tackling the global environmental crisis through sustainable building products. The Company’s innovative technologies allow for fast, efficient development of sustainable, more affordable, durable, and disaster-resilient buildings.
Omicron is one of the largest integrated development services, design, and construction firms in Western Canada. This award-winning, multidisciplined company will enhance Nexii’s operational capabilities with in-house expertise and proven business development, client service, and project delivery processes.
These two Canadian businesses share a vision of revitalizing the construction and building industry through innovation and technology, moving away from traditional practices that are less efficient and significantly contribute to environmental impacts worldwide. Nexii and Omicron have worked as partners since February 2019, when Omicron became one of the early shareholders and adopters of Nexii technology, followed by a range of project collaborations across both teams.
“Omicron and Nexii have been collaborating in several key areas of mutual interest for the last two years, with the shared aim to tackle the construction industry’s main challenge; how to change the way we build in the face of climate change,” Stephen Sidwell, CEO of Nexii says. “Today’s merger formalizes and deepens this relationship and represents a natural strategic evolution for both companies. We are excited to join together to achieve better outcomes for our clients and for the environment.”
Both Nexii and Omicron will retain their business names and separate office headquarters in Vancouver and will continue to service existing clients and projects to completion.
Fort Capital Partners and Mogan Daniels Slager LLP provided financial and legal advice to Nexii in connection with the acquisition of Omicron.